Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entity represents an **antisense non-coding RNA overlapping the PPARGC1A gene**. Antisense transcripts are RNA molecules transcribed from the DNA strand opposite a protein-coding gene, and they can affect the expression, stability, or processing of the sense gene (here, PPARGC1A). There is currently **no published evidence for its functional significance, disease involvement, drug interactions, or recognition as a therapeutic target**. All known functional and disease relevance for PPARGC1A pertain to the sense transcript and its encoded protein, peroxisome proliferator-activated receptor gamma coactivator 1-alpha, which is a major regulator of mitochondrial biogenesis and metabolism.
None known; not a recognized pharmacological target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to peroxisome proliferator-activated receptor gamma coactivator 1-alpha (ENSG00000250137).